Table 11.

Results of MCDA process 4 for each balancing criterion, showing RAIs and PWIs (in %).

C1 :Long-term effectiveness and permanence
	Rank Acceptability Indices				Pairwise Winning Indices
	#1	#2	#3		Alternative 1	Alternative 2	Alternative 3
Alternative 1	0.00	0.00	100.00	Alternative 1	0.00	0.00	0.00
Alternative 2	68.76	31.24	0.00	Alternative 2	100.00	0.00	31.23
Alternative 3	68.77	31.23	0.00	Alternative 3	100.00	31.24	0.00
C2 :Reduction of toxicity, mobility or volume through treatment
	Rank Acceptability Indices				Pairwise Winning Indices
	#1	#2	#3		Alternative 1	Alternative 2	Alternative 3
Alternative 1	0.00	0.00	100.00	Alternative 1	0.00	0.00	0.00
Alternative 2	68.75	31.25	0.00	Alternative 2	100.00	0.00	31.24
Alternative 3	68.76	31.24	0.00	Alternative 3	100.00	31.25	0.00
C3 :Short term effectiveness
	Rank Acceptability Indices				Pairwise Winning Indices
	#1	#2	#3		Alternative 1	Alternative 2	Alternative 3
Alternative 1	1.95	20.29	77.76	Alternative 1	0.00	13.26	0.78
Alternative 2	33.22	53.52	13.26	Alternative 2	80.88	0.00	23.07
Alternative 3	76.93	22.29	0.78	Alternative 3	94.93	66.78	0.00
C4 Implementability
	Rank Acceptability Indices				Pairwise Winning Indices
	#1	#2	#3		Alternative 1	Alternative 2	Alternative 3
Alternative 1	94.19	5.81	0.00	Alternative 1	0.00	92.33	100.00
Alternative 2	7.67	91.84	0.49	Alternative 2	5.81	0.00	99.37
Alternative 3	0.00	0.63	99.36	Alternative 3	0.00	0.49	0.00
C5 :Cost
	Rank Acceptability Indices				Pairwise Winning Indices
	#1	#2	#3		Alternative 1	Alternative 2	Alternative 3
Alternative 1	100.00	0.00	0.00	Alternative 1	0.00	100.00	100.00
Alternative 2	0.00	94.79	5.21	Alternative 2	0.00	0.00	94.79
Alternative 3	0.00	5.21	94.79	Alternative 3	0.00	5.21	0.00